Regenerx Biopharm In Valuation
| RGRXDelisted Stock | USD 0.03 0.01 25.00% |
Regenerx Biopharm seems to be fairly valued based on Macroaxis valuation methodology. Our model determines the value of Regenerx Biopharm from analyzing the company fundamentals such as Shares Outstanding of 143.55 M, shares owned by institutions of 0.01 %, and Return On Asset of -0.84 as well as examining its technical indicators and probability of bankruptcy. . In general, most investors support acquiring undervalued entities and dropping overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Fairly Valued
Today
Please note that Regenerx Biopharm's price fluctuation is very steady at this time. Calculation of the real value of Regenerx Biopharm is based on 3 months time horizon. Increasing Regenerx Biopharm's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Regenerx otc stock is determined by what a typical buyer is willing to pay for full or partial control of Regenerx Biopharm In. Since Regenerx Biopharm is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Regenerx OTC Stock. However, Regenerx Biopharm's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.033 | Real 0.0325 | Hype 0.03 | Naive 0.0455 |
The intrinsic value of Regenerx Biopharm's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Regenerx Biopharm's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Regenerx Biopharm In helps investors to forecast how Regenerx otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Regenerx Biopharm more accurately as focusing exclusively on Regenerx Biopharm's fundamentals will not take into account other important factors: Regenerx Biopharm Total Value Analysis
Regenerx Biopharm In is at this time projected to have valuation of 22.91 M with market capitalization of 20.1 M, debt of 1.14 M, and cash on hands of 478.41 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Regenerx Biopharm fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
22.91 M | 20.1 M | 1.14 M | 478.41 K |
Regenerx Biopharm Investor Information
About 46.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.01. Regenerx Biopharm had not issued any dividends in recent years. Regenerx Biopharm In is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Regenerx Biopharm Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Regenerx Biopharm has an asset utilization ratio of 5.97 percent. This suggests that the OTC Stock is making $0.0597 for each dollar of assets. An increasing asset utilization means that Regenerx Biopharm In is more efficient with each dollar of assets it utilizes for everyday operations.Regenerx Biopharm Ownership Allocation
Regenerx Biopharm has a total of 143.55 Million outstanding shares. Regenerx Biopharm has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.Regenerx Biopharm Profitability Analysis
The company reported the previous year's revenue of 76.76 K. Net Loss for the year was (1.6 M) with profit before overhead, payroll, taxes, and interest of 70.12 K.About Regenerx Biopharm Valuation
Our relative valuation model uses a comparative analysis of Regenerx Biopharm. We calculate exposure to Regenerx Biopharm's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Regenerx Biopharm's related companies.RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland. REGENERX BIOPHARMACEUTICA operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
8 Steps to conduct Regenerx Biopharm's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Regenerx Biopharm's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Regenerx Biopharm's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Regenerx Biopharm's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Regenerx Biopharm's revenue streams: Identify Regenerx Biopharm's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Regenerx Biopharm's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Regenerx Biopharm's growth potential: Evaluate Regenerx Biopharm's management, business model, and growth potential.
- Determine Regenerx Biopharm's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Regenerx Biopharm's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Regenerx Biopharm Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 143.5 M | |
| Retained Earnings | -110.5 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in Regenerx OTC Stock
If you are still planning to invest in Regenerx Biopharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Regenerx Biopharm's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |